FDA Regulation of Xenotransplant
The FDA has some strict regulations for xenotransplants. Their main
concern is of the possibility that a xenotransplant can result in the
spreading of disease from one species to the next. People seeking
FDA approval must be able to submit concrete evidence that the cells
used are safe in this regard. (The Food and Drug Law Institute 1997)
The Rights of Patients for Xenotransplnat studies:
1.a statement of purpose, procedure, and status as experimental
2.reasonably foreseeable risks and discomforts
3.the benefits to the subject and others to be expected from the research
4.alternative treatment options that might benefit the patient
5.the extent of the measures to be taken with respect to the
confidentiality of the party
6.compensation or treatment provided in the event of injury, the nature of
potential injuries, and the sources for additional information
7.a contact for inquiries regarding rights and treatment for
research-related injury
8.a statement of the right to terminate participation at any time without
losing previously-vested rights
For the animal source:

1.animal lineages should be controlled and documented
2.biomedical animal facilities must be within species
3.prescreening of animal sources for known infections
4.maintenance and surveillance of the source herd/colony
5.procedures for procuring and screening xenographs under aseptic
conditions
6.requires archiving the source animal's medical records and specimens
![]()
Brown Biology Home Page | Bio 108 Home Page | Project Home Page | History | Ethics | Procedure | Immunology | Safety | Back To The Top